In 2023, the leukaemia therapeutics treatment market is expected to be worth US$15,246.7 million. The 2022 value, on the other hand, was US$ 14,504.8 million. Through 2033, the market will grow at a CAGR of 7.1%. The market is anticipated to reach US$ 30,318.5 million in valuation by the end of the forecast period. An …